The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review
Sayed, Y.; Garrison, J.M.
Psychopharmacology Bulletin 19(2): 283-288
1983
ISSN/ISBN: 0048-5764 PMID: 6135238 Document Number: 201268
Document emailed within 1 workday
Related Documents
Valchár, M. 1987: Only the dopamine hypothesis in schizophrenia? Ceskoslovenska Psychiatrie 83(2): 98-104Wiesel, F.A. 1994: Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance British Journal of Psychiatry. Suppl 23: 65-70
Hashimoto, K.; Iyo, M. 2002: Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs Nihon Shinkei Seishin Yakurigaku Zasshi 22(1): 3-13
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Haas, H.G.; Kern, R.; Lack, E.G. 1971: The voltage-clamp technique as a tool for testing drugs: the antifibrillatory action of a neuroleptic agent (Droperidol) Arztliche Forschung 25(4): 110-125
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Spaeth, G.L. 1976: The usefulness of pyridoxine in the treatment of homocystinuria: a review of postulated mechanisms of action and a new hypothesis Birth Defects Original Article Series 12(3): 347-357
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Ezrielev, G.Z. 1992: Acute dopamine deficiency and malignant neuroleptic-like syndrome Harefuah 122(8): 503
Wyatt, R.J. 1986: The dopamine hypothesis: variations on a theme (II) Psychopharmacology Bulletin 22(3): 923-927
Jenner, P.; Marsden, C.D. 1988: Adaptive changes in brain dopamine function as a result of neuroleptic treatment Advances in Neurology 49: 417-431
Hyttel, J.; Christensen, A.V. 1983: Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors Journal of Neural Transmission. Supplementum 18: 157-164
Kanba, S.; Kato, T. 2014: Microglial hypothesis of schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 34(1): 11-13
Dalery, J.; D'Amato, T. 1992: Towards a neurodevelopmental hypothesis in schizophrenia L'Encephale 18(2): 155-156
Franck, N.; Georgieff, N. 2002: Neurodevelopmental hypothesis of schizophrenia La Revue du Praticien 52(11): 1202-1207
Ryzhakov, B.A.; Nuller, I.U. 1992: The use of the bromocriptine test in schizophrenia patients resistant to neuroleptic therapy Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(3): 79-80
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
Raevskiĭ, K.S.; Shemanov, A.I.; Kudrin, V.S. 1982: Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis Farmakologiia i Toksikologiia 45(5): 5-8